AMRI has named Dr. Philip William Small as director of chemistry at its Hungarian site. In his new position, Dr. Small will assume responsibilities for all of AMRI's European chemistry related activities including custom synthesis, medicinal chemistry, analytical services, library design and production.
He brings over 20 years of practical and managerial experience in medicinal and combinatorial chemistry gained at leading combinatorial chemistry/drug discovery companies. Most recently, Dr. Small was the vice president and head of high-throughput chemistry operations at Tripos Discovery Research in England, where he was in charge of approximately 90 scientists. In this position, he was responsible for influencing the strategic direction, policies and goals/objectives of the company. He played a major role in successfully developing the company from a staff of 12 people up to 170, and was the project manager for the largest project ever overtaken by Tripos Discovery Research (delivering 400,000 compounds worth $100 million over 4 years).
Prior to Tripos, he held chemistry leadership roles with OSI Pharmaceuticals (Birmingham, UK), Oxford Diversity/OAI (Oxford, UK) and Unilever Research (Merseyside, UK). Dr. Small obtained his Ph.D. degree in organic chemistry from the University of Wolverhampton in 1983.